InvestorsHub Logo
Followers 80
Posts 24704
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 05/23/2019 8:25:20 AM

Thursday, May 23, 2019 8:25:20 AM

Post# of 27623
TYME - 1.45 Pre-market now at 1.55/1.80

TYME and The Joseph Ahmed Foundation Announce Initiation of the HopES Phase II Trial Evaluating the Potential Benefits of SM-88 for Patients with High-Risk Sarcomas

https://www.tradescores.com/StockReport/tyme
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.